Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
6α-Methylprednisolone 21-hemisuccinate sodium salt
Cat. No.:
OB0225LY-0263
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
6α-Methylprednisolone 21-hemisuccinate sodium salt is a synthetic glucocorticoid derivative with strong anti-inflammatory and immunosuppressive effects.
Synonym:
Asmacortone; Methylprodnisolone sodium succinate; Metypresol; Corticel; 6-Methylprednisolone succinate sodium; 2375-03-3; 6alpha-Methylprednisolone 21-hemisuccinate sodium salt; 6-alpha-Methylprednisolone sodium succinate; Sodium 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate
CAS No.:
2375-03-3
Compound CID:
23680530
Formula:
C26H33NaO8
Formula Weight:
496.53
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
6α-Methylprednisolone 21-hemisuccinate sodium salt can be used in cell biology studies to explore the effects of glucocorticoids on immune cell function.
Library Information
Targets:
Glucocorticoid receptor; Glucagon receptor
Pathways:
GPCR/G protein; Endocrinology/Hormones
Plate Number:
AOCL-4
Plate Location:
c9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
18.33 mg/mL; 36.92 mM
